{
  "created_at": "Tue May 25 12:47:52 +0000 2021",
  "id_str": "1397163474011234304",
  "full_text": "Moderna plans to ask regulators next month to approve its Covid-19 vaccine for 12- to 17-year-olds after a study showed it was effective in adolescents https://t.co/qC58dSbt33",
  "display_text_range": [
    0,
    175
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/qC58dSbt33",
        "expanded_url": "https://on.wsj.com/3fl9eoB",
        "display_url": "on.wsj.com/3fl9eoB",
        "indices": [
          152,
          175
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 42,
  "favorite_count": 103,
  "possibly_sensitive": false,
  "original_created_at": "Tue May 25 12:11:44 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Moderna社は、12歳から17歳までの若者を対象としたCovid-19ワクチンの有効性を示す研究結果を受けて、来月、規制当局に承認を求める予定である。https://t.co/qC58dSbt33"
    },
    {
      "locale": "zh",
      "full_text": "Moderna计划在下个月要求监管机构批准其Covid-19疫苗用于12至17岁的青少年，因为一项研究显示该疫苗对青少年有效https://t.co/qC58dSbt33。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "Moderna計劃在下個月要求監管機構批准其Covid-19疫苗用於12至17歲的青少年，因爲一項研究顯示該疫苗對青少年有效https://t.co/qC58dSbt33。"
    }
  ]
}